Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Horak

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncogene Research|May 1, 1988
Post-translational alterations of the tyrosine kinase p56lck in response to activators of protein kinase CA Veillette, I D Horak, J B Bolen
Bailliere'S Clinical Haematology|December 1, 1996
Management of histologically aggressive lymphomas with a high risk of CNS diseaseI D Horak, A B Kremer, I T Magrath
Neoplasma|March 25, 2000
Lack of correlation between repair of DNA interstrand cross-links and differential sensitivity of G0 and proliferating CD4+ lymphocytes towards cisplatinZ Bartosová, I D Horak, M Pirsel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Akathisia associated with prochlorperazine as an antiemetic: a case reportR Dukoff, I D Horak, R Hassan, et al.
Journal of Medicinal Chemistry|October 1, 1993
Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitorsM S Smyth, I Stefanova, I D Horak, et al.
Advances in Cancer Research|January 1, 1991
Expression and interactions of the Src family of tyrosine protein kinases in T lymphocytesJ B Bolen, P A Thompson, E Eiseman, et al.
Journal of Virology|May 1, 1989
Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cellsI D Horak, T Kawakami, F Gregory, et al.
Molecular and Cellular Biology|October 1, 1988
Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activationA Veillette, I D Horak, E M Horak, et al.
Oncogene|April 1, 1990
Expression of p60fyn in human plateletsI D Horak, M L Corcoran, P A Thompson, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six casesC A Sander, L J Medeiros, L V Abruzzo, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncogene Research|May 1, 1988
Post-translational alterations of the tyrosine kinase p56lck in response to activators of protein kinase CA Veillette, I D Horak, J B Bolen
Bailliere'S Clinical Haematology|December 1, 1996
Management of histologically aggressive lymphomas with a high risk of CNS diseaseI D Horak, A B Kremer, I T Magrath
Neoplasma|March 25, 2000
Lack of correlation between repair of DNA interstrand cross-links and differential sensitivity of G0 and proliferating CD4+ lymphocytes towards cisplatinZ Bartosová, I D Horak, M Pirsel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Akathisia associated with prochlorperazine as an antiemetic: a case reportR Dukoff, I D Horak, R Hassan, et al.
Journal of Medicinal Chemistry|October 1, 1993
Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitorsM S Smyth, I Stefanova, I D Horak, et al.
Advances in Cancer Research|January 1, 1991
Expression and interactions of the Src family of tyrosine protein kinases in T lymphocytesJ B Bolen, P A Thompson, E Eiseman, et al.
Journal of Virology|May 1, 1989
Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cellsI D Horak, T Kawakami, F Gregory, et al.
Molecular and Cellular Biology|October 1, 1988
Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activationA Veillette, I D Horak, E M Horak, et al.
Oncogene|April 1, 1990
Expression of p60fyn in human plateletsI D Horak, M L Corcoran, P A Thompson, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six casesC A Sander, L J Medeiros, L V Abruzzo, et al.
Pageof 3